{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T12:01:34Z","timestamp":1794312094185,"version":"4.9.0"},"reference-count":66,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Parkinson\u2019s disease (PD), as a common neurodegenerative disorder, its associated mild cognitive impairment (PD-mild cognitive impairment, PD-MCI) is a key prodromal stage in the progression to PD-dementia (PDD). Cognitive dysfunction seriously affects the quality of life of patients. Early diagnosis of PD-MCI is crucial for the prognosis of the disease. At present, traditional clinical diagnosis mainly relies on neuropsychological tests, but it has limitations such as low sensitivity and being easily interfered by subjective factors. It is difficult to achieve early and accurate identification of PD-MCI, which greatly affects the intervention timing and prognosis of the disease. This article summarizes the research progress of multimodal biomarkers in the early diagnosis of PD-MCI, mainly including the comprehensive application of neuroimaging biomarkers, humoral biomarkers, genetic and molecular biomarkers, digital biomarkers, and clinical assessment, providing new theoretical basis and technical paths for promoting the early diagnosis of PD-MCI. It is of great clinical significance and social value to assist in the formulation of individualized intervention strategies, delay the progression of diseases to dementia, improve the quality of life of patients, and reduce the medical burden on families and society.<\/jats:p>","DOI":"10.3389\/fneur.2025.1652378","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T04:11:30Z","timestamp":1756440690000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Research progress of multimodal biomarkers in the early diagnosis of mild cognitive impairment in Parkinson\u2019s disease"],"prefix":"10.3389","volume":"16","author":[{"given":"Huiping","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengke","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangsheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongchong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baofu","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanming","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1007\/s00415-018-8800-4","article-title":"Mild cogni-tive impairment in Parkinson's disease: the Parkinson's diseasecognitive study(PACOS)","volume":"265","author":"Monastero","year":"2018","journal-title":"J Neurol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1136\/jnnp-2016-315099","article-title":"Stability of mild cognitiveimpairment in newly diagnosed Parkinson's disease","volume":"88","author":"Lawson","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41531-018-0055-3","article-title":"Cognitive impairment inParkinson's disease:a report from a multidisciplinary symposium onunmet needs and future directions to maintain cognitive health","volume":"4","author":"Goldman","year":"2018","journal-title":"NPJ Parkinsons Dis"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"bbad364","DOI":"10.1093\/bib\/bbad364","article-title":"Latent space search based multimodal optimization with personalized edge-network biomarker for multi-purpose early disease prediction","volume":"24","author":"Liang","year":"2023","journal-title":"Brief Bioinform"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.21037\/qims-20-444","article-title":"Meynert nucleus-related cortical thinning in Parkinson's disease with mild cognitive impairment","volume":"11","author":"Rong","year":"2021","journal-title":"Quant Imaging Med Surg"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"103370","DOI":"10.1016\/j.nicl.2023.103370","article-title":"Role of hippocampal subfields in neurodegenerative disease progression analyzed with a multi-scale attention-based network","volume":"38","author":"Xu","year":"2023","journal-title":"Neuroimage Clin"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00401-009-0620-2","article-title":"Are there differences in cerebral white matter lesion burdens between Parkinson's disease patients with or without dementia?","volume":"119","author":"Choi","year":"2020","journal-title":"Acta Neuropathol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1007\/s11682-022-00714-w","article-title":"Cortical atrophy is associated with cognitive impairment in Parkinson's disease: a combined analysis of cortical thickness and functional connectivity","volume":"16","author":"Zhu","year":"2022","journal-title":"Brain Imaging Behav"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1203311","DOI":"10.3389\/fneur.2023.1203311","article-title":"Effects of white matter hyperintensity on cognitive function in PD patients: a meta-analysis","volume":"14","author":"Zhao","year":"2023","journal-title":"Front Neurol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"480","DOI":"10.2174\/1567202617666200901181842","article-title":"Assessment of white matter lesions in Parkinson's disease: voxelbased analysis and tract-based spatial statistics analysis of Parkinson's disease with mild cognitive impairment","volume":"17","author":"Pu","year":"2020","journal-title":"Curr Neurovasc Res"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3389\/fnagi.2016.00247","article-title":"Dysfunction of the default mode network in drug-na\u00efve Parkinson's disease with mild cognitive impairments: a resting-state fMRI study","volume":"8","author":"Hou","year":"2016","journal-title":"Front Aging Neurosci"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00415-014-7591-5","article-title":"Restingstate functional connectivity associated with mild cognitive impairment in Parkinson's disease","volume":"262","author":"Amboni","year":"2015","journal-title":"J Neurol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"111273","DOI":"10.1016\/j.pscychresns.2021.111273","article-title":"Structural and functional neuroimaging changes associated with cognitive impairment and dementia in Parkinson's disease","volume":"312","author":"Owens-Walton","year":"2021","journal-title":"Psychiatry Res Neuroimaging"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"102252","DOI":"10.1016\/j.nicl.2020.102252","article-title":"Mild behavioral impairment in Parkinson's disease is associated with altered corticostriatal connectivity","volume":"26","author":"Lang","year":"2020","journal-title":"NeuroImage: Clinical"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"135672","DOI":"10.1016\/j.neulet.2021.135672","article-title":"Brain activity alterations in patients with Parkinson's disease with cognitive impairment based on resting-state functional MRI","volume":"747","author":"Guo","year":"2021","journal-title":"Neurosci Lett"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.29399\/npa.28209","article-title":"Alterations in large-scale intrinsic connectivity networks in the Parkinson's diseaseassociated cognitive impairment continuum: a systematic review","volume":"59","author":"Ay","year":"2022","journal-title":"Noro Psikiyatr Ars"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1017\/S1355617715000892","article-title":"Salience and default mode network coupling predicts cognition in aging and Parkinson's disease","volume":"22","author":"Putcha","year":"2016","journal-title":"J Int Neuropsychol Soc"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3233\/JPD-230372","article-title":"Effectiveness of continuous dopaminergic therapies in Parkinson's disease: a review of L-DOPA pharmacokinetics\/pharmacodynamics","volume":"14","author":"Demailly","year":"2024","journal-title":"J Parkinsons Dis"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1007\/s00259-025-07137-x","article-title":"Striatal dopamine transporter uptake predicts neuronal hypometabolism and visuospatial function in Parkinson's disease","volume":"52","author":"Seo","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref20","first-page":"2948","article-title":"Decreased raphe connectivity preceding changes of raphe-regional perfusion and SERT expression in drug na\u00efve PD patients with depressive mood","volume":"63","author":"Lee","year":"2022","journal-title":"J Nucl Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/bs.pbr.2022.01.013","article-title":"Cognition and serotonin in Parkinson's disease","volume":"269","author":"Frouni","year":"2022","journal-title":"Prog Brain Res"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3233\/JAD-230570","article-title":"Serotonin degeneration and amyloid-\u03b2 deposition in mild cognitive impairment: relationship to cognitive deficits","volume":"96","author":"Smith","year":"2023","journal-title":"J Alzheimer's Dis"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1195576","DOI":"10.3389\/fneur.2023.1195576","article-title":"Correlation analysis between 18F-fluorodeoxyglucose positron emission tomography and cognitive function in first diagnosed Parkinson\u2019s disease patients","volume":"14","author":"Zhihui","year":"2023","journal-title":"Front Neurol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.parkreldis.2022.02.006","article-title":"Neuroimaging outcomes associated with mild cognitive impairment subtypes in Parkinson's disease: a systematic review","volume":"95","author":"Devignes","year":"2022","journal-title":"Parkinsonism Relat Disord"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1145939","DOI":"10.3389\/fneur.2023.1145939","article-title":"Tau-PET imaging in Parkinson's disease: a systematic review and meta-analysis","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Neurol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e54538","DOI":"10.2196\/54538","article-title":"Integrating biomarkers from virtual reality and magnetic resonance imaging for the early detection of mild cognitive impairment using a multimodal learning approach: validation study","volume":"26","author":"Park","year":"2024","journal-title":"J Med Internet Res"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1093\/brain\/awac176","article-title":"Lipid pathway dysfunction is prevalent in patients with Parkinson's disease","volume":"145","author":"Galper","year":"2022","journal-title":"Brain"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.3390\/life11111239","article-title":"Alpha-synuclein and cognitive decline in Parkinson disease","volume":"11","author":"Fan","year":"2021","journal-title":"Life"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"8976","DOI":"10.3390\/ijms24108976","article-title":"CSF biomarkers in the early diagnosis of mild cognitive impairment and Alzheimer\u2019s disease","volume":"24","author":"Papaliagkas","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41531-023-00627-5","article-title":"CSF \u03b1-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson\u2019s disease","volume":"10","author":"Brockmann","year":"2024","journal-title":"NPJ Parkinsons Dis"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s00401-023-02657-y","article-title":"Distinct tau and alpha-synuclein molecular signatures in Alzheimer\u2019s disease with and without Lewy bodies and Parkinson\u2019s disease with dementia","volume":"147","author":"van der Gaag","year":"2024","journal-title":"Acta Neuropathol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"559","DOI":"10.21037\/atm-20-4583","article-title":"Comprehensive serum metabolic and proteomic characterization on cognitive dysfunction in Parkinson\u2019s disease","volume":"9","author":"Zhang","year":"2021","journal-title":"Ann Transl Med"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"e21895","DOI":"10.1096\/fj.202100787R","article-title":"Plasma extracellular vesicles tau and \u03b2-amyloid as biomarkers of cognitive dysfunction of Parkinson's disease","volume":"35","author":"Chung","year":"2021","journal-title":"FASEB J"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.1111\/ene.15537","article-title":"Different patterns of exosomal \u03b1-synuclein between Parkinson's disease and probable rapid eye movement sleep behavior disorder","volume":"29","author":"Yan","year":"2022","journal-title":"Eur J Neurol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"102249","DOI":"10.1016\/j.jchemneu.2023.102249","article-title":"TNFRSF10B is involved in motor dysfunction in Parkinson's disease by regulating exosomal \u03b1-synuclein secretion from microglia","volume":"129","author":"Dai","year":"2023","journal-title":"J Chem Neuroanat"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"281","DOI":"10.4103\/NRR.NRR-D-24-00592","article-title":"Potential biofluid markers for cognitive impairment in Parkinson\u2019s disease","volume":"21","author":"Chen","year":"2025","journal-title":"Neural Regen Res"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"114463","DOI":"10.1016\/j.expneurol.2023.114463","article-title":"SNAP25 ameliorates postoperative cognitive dysfunction by facilitating PINK1-dependent mitophagy and impeding caspase-3\/GSDME-dependent pyroptosis","volume":"367","author":"Wang","year":"2023","journal-title":"Exp Neurol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s41983-023-00662-2","article-title":"Role of multimodal advanced biomarkers as potential predictors of cognitive and psychiatric aspects of Parkinson's disease","volume":"59","author":"Badr","year":"2023","journal-title":"Egypt J Neurol Psychiatr Neurosurg"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41531-023-00447-7","article-title":"Plasma GFAP in Parkinson\u2019s disease with cognitive impairment and its potential to predict conversion to dementia","volume":"9","author":"Tang","year":"2023","journal-title":"NPJ Parkinsons Dis"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.3390\/biomedicines12122758","article-title":"Machine learning for early detection of cognitive decline in Parkinson's disease using multimodal biomarker and clinical data","volume":"12","author":"Mohammadi","year":"2024","journal-title":"Biomedicine"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"17368","DOI":"10.1038\/s41598-018-35766-w","article-title":"Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease","volume":"8","author":"Lin","year":"2018","journal-title":"Sci Rep"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3390\/diagnostics11020371","article-title":"The role of salivary biomarkers in the early diagnosis of Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"11","author":"Pawlik","year":"2021","journal-title":"Diagnostics"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/agm2.12192","article-title":"Salivary alpha-synuclein as a potential fluid biomarker in Parkinson's disease: a systematic review and meta-analysis","volume":"5","author":"Kharel","year":"2022","journal-title":"Aging Med"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"e29880","DOI":"10.7759\/cureus.29880","article-title":"Prospect of alpha-Synuclein (A-Syn) isolation from saliva as a promising diagnostic biomarker alternative in Parkinson's disease (PD): a systematic review","volume":"14","author":"Muddaloor","year":"2022","journal-title":"Cureus"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"913","DOI":"10.2147\/NDT.S460938","article-title":"Nonlinear relationship between homocysteine and mild cognitive impairment in early Parkinson\u2019s disease: a cross-sectional study","volume":"20","author":"Ouyang","year":"2024","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1080\/10408347.2022.2091920","article-title":"Current progress in aptasensor for ultra-low level monitoring of Parkinson\u2019s disease biomarkers","volume":"54","author":"Margiana","year":"2024","journal-title":"Crit Rev Anal Chem"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1001\/jamaneurol.2020.3311","article-title":"Skin \u03b1-synuclein aggregation seeding activity as a novel biomarker for Parkinson disease","volume":"78","author":"Wang","year":"2021","journal-title":"JAMA Neurol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"e2417","DOI":"10.1212\/WNL.0000000000201199","article-title":"Disease-associated \u03b1-synuclein aggregates as biomarkers of Parkinson disease clinical stage","volume":"99","author":"Majbour","year":"2022","journal-title":"Neurology"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s00415-025-12978-5","article-title":"Skin \u03b1-synuclein assays in diagnosing Parkinson's disease: a systematic review and meta-analysis","volume":"272","author":"Zhao","year":"2025","journal-title":"J Neurol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1091919","DOI":"10.3389\/fnagi.2023.1091919","article-title":"Association of GBA genotype with motor and cognitive decline in Chinese Parkinson\u2019s disease patients","volume":"15","author":"Ren","year":"2023","journal-title":"Front Aging Neurosci"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"4917","DOI":"10.1038\/s41598-021-84316-4","article-title":"Investigating the relationship between the SNCA gene and cognitive abilities in idiopathic Parkinson\u2019s disease using machine learning","volume":"11","author":"Ramezani","year":"2021","journal-title":"Sci Rep"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1038\/s41467-020-16386-3","article-title":"Parkinson's disease associated mutation E46K of \u03b1-synuclein triggers the formation of a distinct fibril structure","volume":"11","author":"Zhao","year":"2020","journal-title":"Nat Commun"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2022.10.016","article-title":"APOE differentially moderates cerebrospinal fluid and plasma phosphorylated tau181 associations with multi-domain cognition","volume":"125","author":"Weigand","year":"2023","journal-title":"Neurobiol Aging"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1093\/cercor\/bht229","article-title":"Resting-state striato-frontal functional connectivity is sensitive to DAT1 genotype and predicts executive function","volume":"25","author":"Gordon","year":"2015","journal-title":"Cereb Cortex"},{"key":"ref55","doi-asserted-by":"crossref","DOI":"10.20944\/preprints202406.0981.v1","article-title":"Epigenetic alterations of cognition functions in Parkinson's disease","author":"Hasani","year":"2024"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"1276288","DOI":"10.3389\/fcell.2024.1276288","article-title":"Epigenome-wide DNA methylation analysis of late-stage mild cognitive impairment","volume":"12","author":"Zhang","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11033-025-10284-x","article-title":"Non-coding RNAs in the pathogenesis of Alzheimer\u2019s disease: \u03b2-amyloid aggregation, tau phosphorylation and neuroinflammation","volume":"52","author":"Jim\u00e9nez-Ram\u00edrez","year":"2025","journal-title":"Mol Biol Rep"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"12379","DOI":"10.3390\/ijms252212379","article-title":"Parkinson\u2019s disease: biomarkers for diagnosis and disease progression","volume":"25","author":"Arya","year":"2024","journal-title":"Int J Mol Sci"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"1070093","DOI":"10.3389\/fnagi.2022.1070093","article-title":"Cognitive parameters can predict change of walking performance in advanced Parkinson's disease - chances and limits of early rehabilitation","volume":"14","author":"Geritz","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"4775","DOI":"10.1002\/alz.13919","article-title":"Remote and unsupervised digital memory assessments can reliably detect cognitive impairment in Alzheimer's disease","volume":"20","author":"Berron","year":"2024","journal-title":"Alzheimers Dement"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1080\/23279095.2022.2147837","article-title":"Which motor-cognitive abilities underlie the digital trail-making test? Decomposing various test scores to detect cognitive impairment in Parkinson's disease-pilot study","volume":"32","author":"Park","year":"2025","journal-title":"Appl Neuropsychol Adult"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"107802","DOI":"10.1016\/j.lungcan.2024.107802","article-title":"Combination of calretinin, MALAT1, and GAS5 as a potential prognostic biomarker to predict disease progression in surgically treated mesothelioma patients","volume":"192","author":"Klotz","year":"2024","journal-title":"Lung Cancer"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"7386","DOI":"10.1007\/s00330-020-07575-1","article-title":"Identifying Parkinson's disease with mild cognitive impairment by using combined MR imaging and electroencephalogram","volume":"31","author":"Zhang","year":"2021","journal-title":"Eur Radiol"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41531-024-00828-6","article-title":"Multimodal neuroimaging-based prediction of Parkinson\u2019s disease with mild cognitive impairment using machine learning technique","volume":"10","author":"Zhu","year":"2024","journal-title":"npj Parkinson's Dis"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e36728","article-title":"Prediction of future dementia among patients with mild cognitive impairment (MCI) by integrating multimodal clinical data","volume":"10","author":"Cirincione","year":"2024","journal-title":"Heliyon"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1111\/jgh.15763","article-title":"Development of novel deep multimodal representation learning-based model for the differentiation of liver tumors on B-mode ultrasound images","volume":"37","author":"Sato","year":"2022","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1652378\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T04:11:31Z","timestamp":1756440691000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1652378\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":66,"alternative-id":["10.3389\/fneur.2025.1652378"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1652378","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,29]]},"article-number":"1652378"}}